Summary
PIPELINE PREVIEWS
See the full content of this document
Extract
FDA approval of Istodax for cutaneous T-cell lymphoma.
Gloucester Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) to start marketing Istodax[R] (ro...
See the full content of this document
Sponsored links
